Cargando…

Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway

Advanced ovarian cancer is a devastating disease. Gaining biomarkers of early detection during ovarian tumorigenesis may lead to earlier diagnosis and better therapeutic strategies. Cystatin B (CSTB) functions as an inhibitor to suppress intracellular cysteine proteases and has been implicated in se...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, XINGXING, GUI, LU, ZHANG, YOUYUAN, ZHANG, JIHONG, SHI, JIMIN, XU, GUOXIONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977810/ https://www.ncbi.nlm.nih.gov/pubmed/24452274 http://dx.doi.org/10.3892/ijo.2014.2261

Ejemplares similares

Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway
por: Sun, Wenwen, et al.
Publicado: (2016)

Cyclin dependent kinase 14 as a paclitaxel-resistant marker regulated by the TGF-β signaling pathway in human ovarian cancer
por: Guan, Wencai, et al.
Publicado: (2023)

Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer
por: Zhang, Lingyun, et al.
Publicado: (2017)

Biological Function of Ribosomal Protein L10 on Cell Behavior in Human Epithelial Ovarian Cancer
por: Shi, Jimin, et al.
Publicado: (2018)

Analysis of the TGFβ functional pathway in epithelial ovarian carcinoma
por: Francis-Thickpenny, K M, et al.
Publicado: (2001)

The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance via the regulation of the TGF-β signal pathway
por: Li, Xin, et al.
Publicado: (2022)

Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer
por: Tian, Xiaoling, et al.
Publicado: (2018)

RBM15-mediating MDR1 mRNA m(6)A methylation regulated by the TGF-β signaling pathway in paclitaxel-resistant ovarian cancer
por: Yuan, Jia, et al.
Publicado: (2023)

Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells
por: Kohan-Ivani, Karla, et al.
Publicado: (2015)

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
por: Yang, Hui-Wen, et al.
Publicado: (2023)

DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway
por: Wang, Daojuan, et al.
Publicado: (2018)

TGFβ signaling networks in ovarian cancer progression and plasticity
por: Kumari, Asha, et al.
Publicado: (2021)

A Negative Feedback Loop Between NAMPT and TGF-β Signaling Pathway in Colorectal Cancer Cells
por: Lv, Xiaoqun, et al.
Publicado: (2021)

The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-β-Induced Epithelial-Mesenchymal Transition
por: Gui, Ting, et al.
Publicado: (2012)

Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma
por: WANG, SHENG-TAN, et al.
Publicado: (2011)

CAF-specific markers: role of the TGFβ pathway
por: Busch, Susann, et al.
Publicado: (2015)

Activation of the LKB1-SIK1 signaling pathway inhibits the TGF-β-mediated epithelial-mesenchymal transition and apoptosis resistance of ovarian carcinoma cells
por: Hong, Bo, et al.
Publicado: (2018)

KRT7 promotes epithelial-mesenchymal transition in ovarian cancer via the TGF-β/Smad2/3 signaling pathway
por: An, Qiang, et al.
Publicado: (2021)

Human amniotic epithelial cells inhibit growth of epithelial ovarian cancer cells via TGF-β1-mediated cell cycle arrest
por: Bu, Shixia, et al.
Publicado: (2017)

Agmatinase facilitates the tumorigenesis of pancreatic adenocarcinoma through the TGFβ/Smad pathway
por: Zhang, Yue, et al.
Publicado: (2022)

Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
por: Shi, Ning, et al.
Publicado: (2022)

EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway
por: Zhao, Guannan, et al.
Publicado: (2021)

RAD51AP1 promotes progression of ovarian cancer via TGF‐β/Smad signalling pathway
por: Zhao, Hongyu, et al.
Publicado: (2020)

Genetic Variants in TGF-β Pathway Are Associated with Ovarian Cancer Risk
por: Yin, Jikai, et al.
Publicado: (2011)

TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells
por: Li, Wenqian, et al.
Publicado: (2017)

Anti-tumor Drug THZ1 Suppresses TGFβ2-mediated EMT in Lens Epithelial Cells via Notch and TGFβ/Smad Signaling Pathway
por: Ning, Jie, et al.
Publicado: (2019)

MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: WANG, SHENGJIE, et al.
Publicado: (2019)

Astragaloside Inhibits Hepatic Fibrosis by Modulation of TGF-β1/Smad Signaling Pathway
por: Yuan, Xingxing, et al.
Publicado: (2018)

Adipose-Derived Stem Cells Facilitate Ovarian Tumor Growth and Metastasis by Promoting Epithelial to Mesenchymal Transition Through Activating the TGF-β Pathway
por: Liu, Xiaowu, et al.
Publicado: (2021)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Cystatin C and Cystatin SN As Possible Soluble Tumor Markers in Malignant Uveal Melanoma
por: Dikovskaya, Maria A., et al.
Publicado: (2021)

Partners in crime: the TGFβ and MAPK pathways in cancer progression
por: Chapnick, Douglas A, et al.
Publicado: (2011)

The activation of microRNA-520h–associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression
por: Zhang, Jing, et al.
Publicado: (2018)

[Corrigendum] MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: Wang, Shengjie, et al.
Publicado: (2023)

HPIP Silencing Prevents Epithelial–Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer Cells
por: Zhang, Guo-ying, et al.
Publicado: (2016)

Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
por: El-Etreby, Nour M., et al.
Publicado: (2017)

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)

Spatial Heterogeneity in Cytoskeletal Mechanics Response to TGF-β1 and Hypoxia Mediates Partial Epithelial-to-Meshenchymal Transition in Epithelial Ovarian Cancer Cells
por: Ghosh, Deepraj, et al.
Publicado: (2023)

Mutation of TGF-β receptor II facilitates human bladder cancer progression through altered TGF-β1 signaling pathway
por: Bian, Jing, et al.
Publicado: (2020)

CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l2qua4jmfit6vdr07iprr9ngh2